Home › Langerhans Cell Histiocytosis › California
Pag-aaral pangklinika para sa Langerhans Cell Histiocytosis sa California
3 pag-aaral para sa Langerhans Cell Histiocytosis ang naghahanap ng mga kalahok sa mga site sa California.
Opisyal na teksto ng pag-aaral (English)
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
- Kaiser Permanente Downey Medical Center, Downey
- Loma Linda University Medical Center, Loma Linda
- Miller Children's and Women's Hospital Long Beach, Long Beach
- at 6 pa
Nagre-recruitPhase 2
180 Days – 22 Years · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05828069Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders
- Children's Hospital of Orange County, Orange
- UCSF Benioff Children's Hospital, San Francisco
Nagre-recruitPhase 2
Lahat ng edad · Lahat ng kasarian · Na-update Set 18, 2025 · NCT04079179Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH)
- Stanford Children's Hospital, Lucile Packard Children's Hospital, Palo Alto
- Rady Children's Hospital - San Diego, San Diego
Nagre-recruitPhase 3
Hanggang edad 21 · Lahat ng kasarian · Na-update Set 11, 2025 · NCT02670707Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.